Technical / White Paper

Identifying the Product


Format: PDF file | Document type: Technical / White Paper

Identifying the Product

When it comes to developing a compound, the 505(b)(2) pathway can make changes to reference products for greater profit potential and lower risk.


Camargo Pharmaceutical Services​ offers a clear process from concept through commercialization to identify products with documented market differentiation:

  • Selection criteria
  • Identify, assess and rank unmet needs
  • Defend value and maximize investment
  • Narrow candidates
  • 505(b)(2) development plan
  • Product case histories


For differentiated product benefits, 505(b)(2) is not just a regulatory platform — it’s a different animal.

Related resources from Camargo Pharmaceutical Services

Show more

Supplier info centre